Blood
and Blood Products
|
Authorised by Charge Nurse - Newborn |
| April 2006 |
| Irradiated Blood | Graft vs Host (GVH) | Hyperviscosity | Hyperosmotic Fluid |
| Haemolysis | Haemolytic Reactions | Risks of Infection |
- Infusing blood rapidly through small gauge needles.
- Infusing through 0.22 micron filter.
- Overheating blood.
- Storage at incorrect temperature.
- Mixing blood with other drugs.
- Mixing dextrose with blood in the giving set (dextrose rapidly enters the red cells and water follows causing the red cells to swell and haemolyse).
- Mixing with sterile water.
Intravascular
- Haemoglobinaemia ((the presence of haemoglobin in the blood plasma).
- Haemoglobinuria (the presence of haemoglobin in the urine).
Extravascular
| Human Immunodeficiency Virus (HIV) | In Australia and NZ approximately 1 million units of blood and blood products are transfused annually. Since 1985 when HIV screening commenced, no known cases of post transfusion HIV infection have been detected. |
| Hepatitis B | Now very rare post transfusion. |
| Hepatitis C | No acute cases of Hepatitis C post transfusion have been detected since HCV screening commenced in 1992. |
| Creutzfeldt-Jakob Disease (CJD) | There are no clearly documented cases of CJD being passed on by blood products. However it remains a theoretical possibility. This may be markedly reduced with pre-storage filtering of blood. |
| Cytomegalovirus (CMV) | Occasional cases occur but are relatively rare. Neonatal transfused red blood cells are leukodepleted and CMV antibody negative, |